Skip to content
PreclinicalResearch compoundLimited evidence

P7C3

Experimental nerve-protecting compound: protected brain cells in animals, not yet studied in humans, not approved as a medicine.

NootropicNeuroprotectantLongevityNeuroprotectionNeurotrophinsnoo.affects.neurotrophinsnoo.affects.memorynoo.affects.mitochondrianoo.affects.nad

Pharmacology

ClassNeuroprotection · Neurotrophins
Primary targetNAMPT enzyme activation (NAD+ salvage pathway)
Targets4 receptor targets
Half-lifeNot characterized in humans (optimized analogues such as P7C3-A20 are orally bioavailable and cross the blood-brain barrier in rodents)
OnsetNo human data
EvidenceLimited evidence
Affected systemsnoo.affects.neurotrophinsnoo.affects.memorynoo.affects.mitochondrianoo.affects.nad

Contents

DETAILED OVERVIEW

What is P7C3?

P7C3 is an experimental compound found through laboratory screening: in adult animals it stimulates the formation of new nerve cells in the hippocampus, a brain area linked to memory. It has not been approved as a medicine anywhere, it is available only as a research chemical, and it is not meant for human consumption.

It switches on an enzyme that replenishes a helper molecule of cell energy production called NAD+, which restores its level in stressed or injured nerve cells and helps them survive. In rodents and primates it protected nerve cells in models of stroke, brain injury and degenerative brain diseases, and it eased symptoms in animals modelling depression. It has so far been studied only in animals, it is not proven in humans, and there are no human safety data. A theoretical concern about liver damage arose with early versions; in cancer, altering the NAD+ pathway calls for caution, and in pregnancy and breastfeeding its safety is not established.

Mechanism

Activation of an enzyme that replenishes NAD+ (NAMPT)

Evidence

Preclinical only (no human data)

Legal status

Unapproved research chemical

Receptor profile

  • NAMPT enzyme (NAD+ salvage)Strong
  • Hippocampal neurogenesisStrong
  • Mitochondrial functionModerate
  • Neuronal apoptosis (inhibition)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • No human safety data: all evidence comes from preclinical (rodent and primate) studies; the compound has never been tested in humans
  • Unknown long-term safety and incomplete toxicity profile in humans
  • Theoretical hepatotoxicity concern was raised for early P7C3 variants; the optimized analogues (P7C3-A20, P7C3-S243) were developed partly to reduce this
  • Systemic consequences of modulating NAD+ metabolism are not characterized in humans

Contraindications · 3

  • Pregnancy and breastfeeding: safety not established, avoid
  • Not an approved medicine; experimental research chemical, not recommended without clinical supervision
  • Known or suspected malignancy: modulating the NAMPT/NAD+ pathway warrants caution in an oncological context

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

P7C3 is a strictly experimental, research-only compound studied in animal models mainly for protecting brain cells and stimulating regrowth in the memory-related region of the brain, for example in models of brain injury or stroke. Research suggests it may help keep nerve cells viable under stressful conditions, and it has also shown mood-lifting, antidepressant-like effects in animals. It is important to stress that this is a purely preclinical substance, limited to animal studies, with essentially no human data or experience available.

Telegram

Have a question about P7C3?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC21H18Br2N2O
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.